GR1004204B - Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses - Google Patents

Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses

Info

Publication number
GR1004204B
GR1004204B GR990100331A GR990100331A GR1004204B GR 1004204 B GR1004204 B GR 1004204B GR 990100331 A GR990100331 A GR 990100331A GR 990100331 A GR990100331 A GR 990100331A GR 1004204 B GR1004204 B GR 1004204B
Authority
GR
Greece
Prior art keywords
genetic
diagnostic
amniotic
human cells
future therapeutic
Prior art date
Application number
GR990100331A
Other languages
Greek (el)
Other versions
GR990100331A (en
Inventor
Original Assignee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by filed Critical
Publication of GR990100331A publication Critical patent/GR990100331A/en
Publication of GR1004204B publication Critical patent/GR1004204B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

his invenion belongs to the field of biotechnology, cryobiology and human therapeutics. Object of the invention are a) amniotic cells originating from amniotic fluid that surrounds the embryo in its early development stages, c) every biological material which will be created directly of idirectly from the above amniotic cells, as well as every biological product or byproduct which will be the outcome of the use of the said cryopreserved amniotic cells, through their reproduction on multiplication under the same or any other modified form and which will possess the same genetic properties and applications.
GR990100331A 1999-09-29 1999-09-29 Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses GR1004204B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR99100331 1999-09-29

Publications (2)

Publication Number Publication Date
GR990100331A GR990100331A (en) 2001-05-31
GR1004204B true GR1004204B (en) 2003-09-05

Family

ID=10943929

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990100331A GR1004204B (en) 1999-09-29 1999-09-29 Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses

Country Status (3)

Country Link
AU (1) AU7437900A (en)
GR (1) GR1004204B (en)
WO (1) WO2001023532A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2548643A1 (en) * 2003-04-07 2004-10-28 Neostem, Inc. System capable of treating and defining various diseases using stem cells
US7569385B2 (en) 2003-08-14 2009-08-04 The Regents Of The University Of California Multipotent amniotic fetal stem cells
WO2005072790A1 (en) 2004-02-02 2005-08-11 I.M.T. Interface Multigrad Technology Ltd. Device for directional cooling of biological matter
WO2005072523A2 (en) 2004-02-02 2005-08-11 I.M.T. Interface Multigrad Technology Ltd. Biological material and methods and solutions for preservation thereof
JP5096148B2 (en) 2004-06-07 2012-12-12 コア・ダイナミクス・リミテッド Method for disinfecting biological samples
WO2006016372A1 (en) 2004-08-12 2006-02-16 I.M.T. Interface Multigrad Technology Ltd. Method and apparatus for freezing or thawing of a biological material
US8198085B2 (en) 2005-08-03 2012-06-12 Core Dynamics Limited Somatic cells for use in cell therapy
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
CA3177726A1 (en) 2015-05-21 2016-11-24 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8803697D0 (en) * 1988-02-17 1988-03-16 Deltanine Research Ltd Clinical developments using amniotic membrane cells
US5405751A (en) * 1994-01-12 1995-04-11 Schering Corporation Prenatal diagnosis by cytokine-induced proliferation of fetal T-cells
DE69726054D1 (en) * 1996-01-23 2003-12-18 Srl Inc CELLS FOR THE TREATMENT OF DEMENTIA
US5897987A (en) * 1996-03-25 1999-04-27 Advanced Reproduction Technologies, Inc. Use of arabinogalactan in cell cryopreservation media
AU4860900A (en) * 1999-06-02 2000-12-18 Lifebank Services, L.L.C. Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells

Also Published As

Publication number Publication date
WO2001023532A1 (en) 2001-04-05
AU7437900A (en) 2001-04-30
GR990100331A (en) 2001-05-31

Similar Documents

Publication Publication Date Title
EP1784639A4 (en) METHODS FOR PREPARING LYOPHILIZED PLAQUETTES, COMPOSITIONS CONTAINING THE LYOPHILIZED PLAQUETTES, AND METHODS OF USE THEREOF
DK1053256T3 (en) Antibodies to Death Receptor 4 (DR4) and Applications thereof
YU9403A (en) Anti-dual integrin antibodies, compositions, methods and uses
GR1004204B (en) Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses
MA68598B1 (en) METHODS FOR PRODUCING TUMOR-INFILTRATING LYMPHOCYTES AND THEIR USES IN IMMUNOTHERAPY
MXPA03005273A (en) Prokaryotically produced antibodies and uses thereof.
EP2289939A3 (en) PAN-KIR2DL NK-receptor antibodies and their use in diagnostic and therapy
CA2530416A1 (en) Postpartum cells derived from placental tissue, and methods of making and using the same
ATE280226T1 (en) GENETIC MARKERS FOR BREAST AND Ovarian CANCER
ECSP105739A (en) NEUTRALIZATION ANTIBODIES AGAINST GDF-8
ATE437663T1 (en) ALLOY COMPOSITIONS AND DEVICES CONTAINING SAME
BRPI0410342A (en) stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and processes for producing
DK1448229T3 (en) Pharmaceutical composition for inducing an immune response in a human or animal
PL356846A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
EP0769968A4 (en) RETROVIRAL VECTORS PRODUCED BY HUMAN SERUM LYSE RESISTANT PRODUCT CELL LINES
WO2007070640A3 (en) Use of roma for characterizing genomic rearrangements
FR2586428B1 (en) POLYPEPTIDES AND ANTIBODIES, CHARACTERISTICS OF PAPILLOMAVIRUS AND THEIR APPLICATIONS TO IN VITRO DIAGNOSIS, PREVENTION AND / OR CONTROL OF PAPILLOMAVIRUS INFECTIONS
WO2004046332A3 (en) Amplified genes involved in cancer
MY147516A (en) Compositions and method of vascular injury repair cross-reference to related applications
WO2003100000A3 (en) Amplification and overexpression of oncogenes
TR200100637T2 (en) New natural product derivatives
BR9910650A (en) Modification of hardness of ceral organ through expression of pureindoline proteins
WO2003076610A3 (en) Variants of human kallikrein-2 and kallikrein-3 and uses thereof
WO2007067905A3 (en) THERAPEUTIC USE FOR α1 PROTEINASE INHIBITOR IN HEMATOPOIESIS
Ma et al. Natural killer cells, as the rising point in tissues, are forgotten in the kidney

Legal Events

Date Code Title Description
PG Patent granted
ML Lapse due to non-payment of fees

Effective date: 20120403